Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When tomorrow comes and we are no longer covered by sec rule 201 does anyone expect selling to re-start?
thanks for clarifying wook, appreciate it!
Are you suggesting that coding and dosing in the first line NSCLC trial was screwed up in the same way that the 2nd line NSCLC trials was???
dlucky from the yahoo board posted some questions for the potential CC in "the next month or so". I copied them below:
1. The ability to purify Perkinamine material, why does it start with NR, not Indigo? With LSS using Indigo, isn't it the most urgent and important?
2. Timeline for establishing Perkinamine Indigo repeatability prior to final testing by the customer. The customer must have a deadline.
3. What is expected to be the first prototype, SLM, Electro-Optical switch? timeline?
4. Funding beyond the 3rd quarter, is it on the agenda yet? what has been explored?
Anyone have any others?
Has JJ said how he intends to raise the necessary cash to fund US trials and bring the Hemopurifier to market? I haven't been following this company very closely since 2010. Also, any idea as to the length of time it takes to get a medical device approved these days?
TIA
I am not trying to start a rumor, apologies if it came off that way. I only meant to say that once they are approved for their 10 patient trial in United States and show excellent effectiveness and safety, that they may want to start considering uplisting to get off the bulletin board exchanges and be able to attract credible institutional investors and raise the necessary cash to bring the Hemopurifier to market. To accomplish this would require a MUCH higher share price (in terms of multiples of current share price) from where they are now but IMO they wouldn't need to consider a R/S until they get closer to FDA approval of the product.
Yea that would make sense. I think I saw Worldcom on there too which had it's own scandal.
The 2012 list is pretty fantastic, couldn't complain if we inked a deal with any of the relevant companies on it (although we all have our preferences). Fingers crossed Lightwave nails down the dye loading soon with spectacular results.
On another note it sounds like they might expect to announce something in the next 30-45 days per the recent update:
"we are discussing the possibility of scheduling a conference call in the next month or so to provide our shareholders with additional information and the opportunity to submit their own questions."
Can't imagine they would mention possibly scheduling a conference call for just another ho-hum update and Q&A...
The good thing about where we are now calendar-wise is that the holiday season is over so they can get back on track 100% (and without the thin film issues). Lightwave has money to last through Q3 2013 so they'll need to start raising money at least by the end of Q2 which gives them 6 months to show investors and everyone else products or potential worth investing in. It would be hard to fathom not having any contracts or working devices by the end of June although we've been disappointed every year so far.
If they hold the conference call I'd like to ask them when they expect to demonstrate a working device.
I know it isn't popular but I feel as though a reverse split would really help this company.
Seeing Enron on that list makes me believe it's a bit out-dated.
Once efficacy and safety are shown in the 10 patient study with RRI, I'd imagine it will start to gain some recognition and traction with other indications (and also on the street?). Would love to see an MD Anderson study for cancer using the hemopurifier for exosome removal in conjunction with standard of care.
Does Aethlon have to file an IDE for each disease/function that the company intends to use the Hemopurifier for? I am surprised that the IDE only covers Hep C but maybe I shouldn't be?
Renal Research Institute is a joint partnership between Beth Israel and Fresenius by the way, so now there is officially a link between the two companies.
Does anyone care to guess if they'll have a Telecom or SLM complete and ready for demonstration by end of the first quarter???
More competition (company is called Solar Junction) also using tech from NREL:
Award-winning PV cell pushes efficiency higher
http://phys.org/news/2013-01-award-winning-pv-cell-efficiency-higher.html
Phys.org)—It takes outside-the-box thinking to outsmart the solar spectrum and set a world record for solar cell efficiency. The solar spectrum has boundaries and immutable rules. No matter how much solar cell manufacturers want to bend those rules, they can't. So how can we make a solar cell that has a higher efficiency than the rules allow? That's the question scientists in the III-V Multijunction Photovoltaics Group at the U.S. Department of Energy's (DOE) National Renewable Energy Laboratory (NREL) faced 15 years ago as they searched for materials they could grow easily that also have the ideal combinations of band gaps for converting photons from the sun into electricity with unprecedented efficiency. A band gap is an energy that characterizes how a semiconductor material absorbs photons, and how efficiently a solar cell made from that material can extract the useful energy from those photons. "The ideal band gaps for a solar cell are determined by the solar spectrum," said Daniel Friedman, manager of the NREL III-V Multijunction Photovoltaics Group. "There's no way around that." But this year, Friedman's team succeeded so spectacularly in bending the rules of the solar spectrum that NREL and its industry partner, Solar Junction, won a coveted R&D 100 award from R&D Magazine for a world-record multijunction solar cell. The three-layered cell, SJ3, converted 43.5% of the energy in sunlight into electrical energy—a rate that has stimulated demand for the cell to be used in concentrator photovoltaic (CPV) arrays for utility-scale energy production. Last month, that record of 43.5% efficiency at 415 suns was eclipsed with a 44% efficiency at 947 suns. Both records were verified by NREL. This is NREL's third R&D 100 award for advances in ultra-high-efficiency multijunction cells. CPV technology gains efficiency by using low-cost lenses to multiply the sun's intensity, which scientists refer to as numbers of suns. Friedman says earlier success with multijunction cells—layered semiconductors each optimized to capture different wavelengths of light at their junctions—gave NREL a head start. The SJ3 cells fit into the market for utility-scale CPV projects. They're designed for application under sunlight concentrated to 1,000 times its normal intensity by low-cost lenses that gather the light and direct it at each cell. In regions of clear atmosphere and intense sunlight, such as the U.S. desert Southwest, CPV has outstanding potential for lowest-cost solar electricity. There is enough available sunlight in these areas to supply the electrical energy needs of the entire United States many times over. Bending Material to the Band Gaps on the Solar Spectrum Sunlight is made up of photons of a wide range of energies from roughly zero to four electron volts (eV). This broad range of energies presents a fundamental challenge to conventional solar cells, which have a single photovoltaic junction with a single characteristic band gap energy. Conventional cells most efficiently convert those photons that very nearly match the band gap of the semiconductors in the cell. Higher-energy photons give up their excess energy to the solar cell as waste heat, while lower-energy photons are not collected by the solar cell, and their energy is completely lost. This behavior sets a fundamental limit on the efficiency of a conventional solar cell. Scientists overcome this limitation by using multijunction solar cells. Using multiple layers of materials in the cells, they create multiple junctions, each with different band gap energies. Each converts a different energy range of the solar spectrum. An invention in the mid-1980s by NREL's Jerry Olson and Sarah Kurtz led to the first practical, commercial multijunction solar cell, a GaInP/GaAs two-junction cell with 1.85-eV and 1.4-eV bandgaps that was recognized with an R&D 100 award in 1990, and later to the three-junction commercial cell based on GaInP/GaAs/Ge that won an R&D 100 award in 2001. The researchers at NREL knew that if they could replace the 0.67-eV third junction with one better tuned to the solar spectrum, the resulting cell would capture more of the sun's light throughout the day. But they needed a material that had an atomic structure that matched the lattice of the layer above it—and that also had the ideal band gap. "We knew from the shape of the solar spectrum and modeling solar cells that what we wanted was a third junction that has a band gap of about 1.0 electron volt, lattice-matched to gallium arsenide," Friedman said. "The lattice match makes materials easier to grow." They concentrated on materials from the third and fifth columns of the periodic table because these so-called III-V semiconductors have similar crystal structures and ideal diffusion, absorption, and mobility properties for solar cells. But there was seemingly no way to capture the benefits of the gallium arsenide material while matching the lattice of the layer below, because no known III-V material compatible with gallium arsenide growth had both the desired 1-eV band gap and the lattice-constant match to gallium arsenide. That changed in the early 1990s, when a research group at NTT Laboratories in Tokyo working on an unrelated problem made an unexpected discovery. Even though gallium nitride has a higher band gap than gallium arsenide, when you add a bit of nitrogen to gallium arsenide, the band gap shrinks—exactly the opposite of what was expected to happen. EnlargeNREL Principal Scientist Jerry Olson holds examples of the first multijunction cells that were developed in the 1980s based on his scientific breakthrough."That was very surprising, and it stimulated a great deal of work all over the world, including here at NREL," Friedman said. "It helped push us to start making solar cells with this new dilute nitride material." Good Band Gaps, but Not So Good Solar Material The new solar cells NREL developed had two things going for them—and one big issue. "The good things were that we could make the material very easily, and we did get the band gap and the lattice match that we wanted," Friedman said. "The bad thing was that it wasn't a good solar cell material. It wasn't very good at converting absorbed photons into electrical energy. Materials quality is critical for high-performance solar cells, so this was a big problem." Still, NREL continued to search for a solution. "We worked on it for quite a while, and we got to a point where we realized we had to choose between two ways of collecting current from a solar cell," Friedman said. "One way is to let the electrical carriers just diffuse along without the aid of an electric field. That's what you do if you have good material." If the material isn't good, though, "you have to introduce an electric field to sweep the carriers out before they recombine and are lost," Friedman said. But to do that, virtually all impurities would have to be removed. And the only way to remove the impurities would be to use a different growth technique. Using Molecular Beam Epitaxy to Virtually Eliminate Impurities Solar cells are typically grown using metalorganic vapor-phase epitaxy, or MOVPE. "It works great, except you always get a certain level of impurities in the material. That's usually not a problem, but it would be an issue for this novel material, with the gallium arsenide diluted with nitrogen," Friedman said. A different growth technique, molecular beam epitaxy (MBE), is done in such an ultra-high vacuum—10 to the minus 13 atmospheres—that it can lower the impurities to the point where an electric field can be created in the resulting photovoltaic junction. And that would make the otherwise promising gallium-arsenide-dilute-nitride material work as a solar cell. "The only problem was that there was no one in the entire world manufacturing solar cells by MBE," Friedman said. But that was soon to change. Partnering with a Startup out of Stanford University: Solar Junction A Stanford University research group with expertise in the use of MBE for other electronic devices saw an opportunity, and around 2007, they spun out a startup company they named Solar Junction. Because Solar Junction was a mix of enthusiastic recent Ph.D.s and experienced hands from outside the established solar cell field, "they weren't tied to the constraints of thinking this couldn't be done, that the only economically viable way to make solar cells was with MOVPE," Friedman said. The federal lab and the startup got together. Solar Junction won a $3 million DOE/NREL Photovoltaic Technology Incubator contract to develop a commercial multijunction cell using dilute nitrides, and also received more than $30 million of venture-capital funding for this commercialization effort. "So Solar Junction had this good idea. But now they had to prove that you could actually make a high-efficiency solar cell with this," Friedman said. "Otherwise, who cares? People can make a lot of claims, but it's very simple to know whether you have a good solar cell or not—you just measure it." It didn't take that long, Friedman said. By 2011, NREL had certified a new efficiency record for Solar Junction's SJ3 cell. The cell achieved an efficiency of 43.5% under concentrated sunlight, a significant step beyond the previous multijunction efficiency record of 41.6%, and far beyond the maximum theoretical efficiency of 34% for traditional one-sun single-junction cells. Dilute-Nitride Junction Eliminates Need for Heavy Germanium Layer With the new dilute-nitride junction, the germanium layer, which constitutes about 90% of the weight of the cell, is no longer needed. That may not be a big deal when it's part of a huge fixed utility-scale array. But when solar cells are used to power satellites, reduction in weight means a smaller rocket is needed to launch into space, potentially reducing costs significantly. The lighter weight is also essential for the military, which is increasingly asking soldiers to carry backpacks that include solar devices to power electronics. Serendipitously, if the germanium substrate is retained, it has essentially the ideal band gap of 0.7 eV for a fourth junction, perfect for capturing longer wavelengths of the solar spectrum. That paves the way for a 50%-efficient solar cell in the not-distant future. The cost to manufacture the SJ3 cell is competitive with that of the industry-standard GaInP/GaAs/Ge cell, according to Solar Junction. Its greater efficiency translates to significant cost-of-energy savings. According to a report released this fall from IMS Research, the CPV market is forecast to double in 2012 and reach almost 90 megawatts. The World Market for Concentrated PV (CPV)—2012 predicts installations of CPV will grow rapidly over the next five years to reach 1.2 gigawatts by 2016. Because of its design and size, SJ3 is an instant plug-in replacement for the standard cell now used by the space and CPV industries. So, for example, if a 40%-efficient cell were replaced with a 44%-efficient cell, this would instantly increase the entire system power output by close to 10%. "This is really a classic example of NREL developing something and then industry picking it up and running with it and making it a great commercial success," Friedman said. "We started with some very basic materials research. We took it to the point where it made sense for industry to take over and take it to the marketplace." "We conceived the cell, demonstrated the individual parts, and let the world know about it," Friedman said. "But Solar Junction put all the parts together with record-breaking results, made it work with MBE, and commercialized it at a time when no one else seemed to be interested in or able to do it." And now, utilities are ordering the SJ3 cells so fast that Solar Junction has depleted its pilot-scale stock and gone into partnership with manufacturer IQE to ramp up to full manufacturing scale.
Read more at: http://phys.org/news/2013-01-award-winning-pv-cell-efficiency-higher.html#jCp
As far as the project with the LSS goes, they must be getting close to figuring out the best dye loading percentage and solving repeatability issues as they've been working on it since the 10/31/12 update, right?
"We are presently working on achieving the chromophore (dye) loading and polling the materials on test substrates before we attempt to coat finished proprietary devices." - From the 10/31/12 update.
From the 12/31/12 update:
"We are presently testing the electro-optical activity and experimenting with different chromophore loading percentages to determine the effect on the electro-optic activity before we coat proprietary devices. It is critical for us to establish repeatability in our process prior to final testing by our potential customer. "
"With so many game-changing opportunities arising as we move our company forward"
Game-changing hmm? I want to believe them but it's getting hard after the past several years of using that turn of phrase. Maybe we do need the conference call to get us all excited again. If we're going to have to wait a while longer for anything significant it'd be nice to know what we are waiting for that could be "game-changing" and why.
Not much new information in the update although it sounds like progress is being made (albeit slowly) in most areas. Due to the potential conference call "in the next month or so" it sounds like they are still some time away from any major milestones especially if it is basically just a Q&A session. The potential business combination does not sound certain anymore either. BIG sigh...
Lightwave Logic Chairman & CEO, Tom Zelibor Provides Year-End Update to Shareholders
Reports Significant Progress Toward Commercialization of Groundbreaking Organic Nonlinear Electro-Optical and All-Optical Polymers
Re-signs Dr. Fred Leonberger as Scientific Advisor for 2013
Reports Issuance of New Patent
NEWARK, Del., Dec. 31, 2012 /PRNewswire/ -- Tom Zelibor, Chairman and Chief Executive Officer of Lightwave Logic, Inc. (OTC:LWLG), a technology company focused on the development of a Next Generation Non Linear Optical Polymer Materials Platform for applications in high speed fiber-optic data communications and optical computing, provided the following comprehensive year-end update to shareholders:
2012 has been a key turnaround year for Lightwave Logic. As we enter 2013, we are a much more focused enterprise with significant activities in progress that are moving us forward in several of our areas of operation.
Business Analysis/Rationalization
As we disclosed at the 2012 annual shareholder meeting and in subsequent updates, we've spent a significant amount of time analyzing and rationalizing all of the major components of our business; reorganized operations; added key personnel; consolidated our university collaborations; and made significant investments in capital equipment, including the construction of a new chemical synthesis laboratory and a separate optical testing facility. This involved a complex, coordinated effort that involved the entire team, which we successfully implemented in record time.
Commercialization Efforts
On the commercialization front, we have made significant advances in our next generation non- linear optical polymer material platform including the ability to purify Perkinamine NRTM, achieving a crystalline structure with 98.9% purity, which is vital to be able to manufacture commercial quantities of our materials. In addition, in order to alter the molecule's properties for expanded commercial uses, we needed to know exactly what molecular structures we were changing. We will follow the same process with the balance of our PerkinamineTM Family of chromophores later.
Through our collaboration with Dr. Alan Mickelson at the University of Colorado Boulder, we have significantly advanced our microelectronics effort using Perkinamine IndigoTM, which has given us the ability to make exceptional quality polymer films at specified thicknesses that are almost 50% thinner than what we have previously been able to achieve. We are presently testing the electro-optical activity and experimenting with different chromophore loading percentages to determine the effect on the electro-optic activity before we coat proprietary devices. It is critical for us to establish repeatability in our process prior to final testing by our potential customer.
The ability to make quality films was one of the problems that that we identified as a common denominator impacting our progress. We now believe that we have solved this and should reignite progress in some of our other prototype projects like the spatial light modulator that has been delayed for the same reason.
It is important for you to understand that in the process of commercializing our technology, there are various processes that we must master and I caution you to not misconstrue comments that can easily be taken out of context. For example, being done with the initial synthesis of a material does not mean we are done testing its characteristics and does not mean we are done with fabricating a device with it. Each device has its own particular specifications that can generate numerous engineering hurdles to overcome.
We are proceeding toward our goal of developing an all-optical switch using Perkinamine NRTM for an Intelligence Community customer of Celestech. We have submitted various white papers, however, certain issues regarding security clearances have prevented us from directly interfacing with their customer. That may not make sense to you since I have an extensive background in this area. However, pursuant to DOD 5220.22-R, Industrial Security Regulation (ISR), and DOD 5220.22-M, National Industrial Security Program Operating Manual (NISPOM), in order to reactivate my current security clearance, we need to be engaged in an active contract that requires a certain clearance level. This would result in the issuance of a DD Form 254, Contract Security Classification Specification for me. We are presently attempting to work our way around this obstacle to obtain the necessary clearances.
We are very excited by the commercial prospects here, especially after the Air Force Research Lab confirmed a femtosecond response time in our Perkinamine NRTM. As you may recall, Lehigh University could only determine a picosecond response time due to the capability of their equipment. This is 1,000 times faster than previously thought.
Patent/Personnel Update
US Patent No. 8,298,326 Tricyclic Spacer Systems for Nonlinear Optical Devices
On October 30, 2012, the United States Patent Office (USPTO) issued Patent No. 8,298,326, titled: Tricyclic Spacer Systems for Nonlinear Optical Devices to Lightwave Logic. The claim in this divisional patent was originally part of a previously issued patent. The USPTO will not allow multiple inventions within a single patent. This is our third issued patent.
Our spacer systems are an important component of our company's intellectual property and improve the solubility of its chromophores (dyes) that must be dissolved into organic polymer substrates. Chromophores are organic materials that impart light sensitivity to the resulting organic nonlinear polymer, but have a tendency dimerize. This term describes a tendency of opposite ends of the molecule to be strongly attracted to each other. Spacer systems prevent this from happening and are necessary for the polymer to be subsequently poled. Poling causes the alignment of the electro-optic polymer's molecules, which is necessary to facilitate the switching of light.
We are also pleased to inform you that Dr. Fred Leonberger has accepted our offer to remain as a senior advisor to our company for an additional year. Fred has agreed to expand his role to be an advisor to our Board of Directors, as well. Fred is a world-renowned expert in optical devices and is a key contributor to our efforts to manufacture commercial devices. He is currently actively engaged in the due diligence efforts we are conducting on companies we are considering for future business combinations. I cannot emphasize enough the value and expertise that Fred brings to our company.
I would also like to inform you that as a result of the progress we have made with our materials development this past year, we are moving our current Chief Technology Officer, Lou Glasgow, to part-time status. This is not saying that we have solved all of our materials issues; since Lou will remain significantly involved with materials development along with the additional organic synthesis capability we obtained with the addition of Babu Sundar to our team. However, the CTO role is evolving to require more focus and expertise with optical devices and commercialization, rather than material development, and I do not see a need at this time to expend the cash (we have enough cash on hand to get us through 3rd quarter of 2013) for a full-time position, given these circumstances. Furthermore, in connection with our effort to engage in a business partnership/acquisition, a by-product of that transaction could likely provide us with a person who has optical device expertise and could assume a full-time CTO role with our company to focus on the practical aspect of devices and commercialization.
Corporate Developments
As you were informed you at our August 2012 shareholder meeting, we have identified and entered into substantive negotiations with a potential business partner/acquisition target that fits most of our major business criteria. We have recently concluded a detailed analysis of the business synergies and we are excited by the potential. I am not at liberty to discuss any details at this time, except that we are moving the negotiations forward and we remain hopeful that we can reach an agreement, although we cannot guarantee you at this time that an agreement will occur. The timeline to conclusion is hard to predict due to the many variables and number of people involved, but we are working hard to make it happen.
With so many game-changing opportunities arising as we move our company forward, we are discussing the possibility of scheduling a conference call in the next month or so to provide our shareholders with additional information and the opportunity to submit their own questions. I am excited about our prospects for 2013. We appreciate your support and wish everyone the very best for a prosperous New Year.
Well, at least the device is ready for when the material is ironed out. I wonder if they are trying to use the same quality films/dye loading for the Telecom modulator that the LSS is requiring.
Just to clarify, it was a "bench top" telecom modulator by Fred's design that was supposed to be due by end of this year, not the SLM. Of course, the completion of the telecom modulator was "subject to the successful characterization" of materials both in and outside of devices which is still an ongoing process it seems.
The SLM project is being worked on by Boulder Nonlinear Systems and the project is expected to "run into" Q1 2013
The lack of communication might be due in part to the fact that Lightwave isn't low on cash. Management might not feel the pressure to communicate as much when it isn't necessary for them to keep the share price over a dollar so that they can continue to tap LPC.
Walter, thanks for getting in touch with management. Hopefully it spurs some action.
I realize that solar is no longer a focus for Lightwave but I was checking out Arduengo's website and noticed something that may or may not have already been mentioned:
http://ajarduengo.net/Research.html
"A new series of proprietary dyes (Bamaphoresâ„¢) developed at Alabama have now been integrated into functional Solar Photovoltaic Cells and show good response to natural light and much superior activity and stability compared to competitive dyes tested. Further optimization of these dyes and the photocell configuration to produce the highest possible photocurrent is ongoing."
I didn't realize that Arduengo had already integrated the Bamaphores into solar cells, looks like he's making progress. It will be interesting to see the results of his work. On another note I hope that it doesn't take Michelson 2+ years to make headway with projects involving Perk!
I'm thinking we might be a little late for a Christmas miracle. Might want to start wishing for an MLK day miracle?
Well, they have +98% purity down for Perk NR. Regular Perk shouldn't be too far behind if they haven't already figured it out. The materials mystery for me is where they're at with Indigo. I asked IR about that around a month ago and all I received for a reply was "Indigo is a different structure" which doesn't indicate either way whether they need to purify it or not....and thoroughly ticked me off as a result lol...
I hope you're right. It would make for a crappy stocking stuffer if it was due to anything else.
On another note, I still feel as though hearing about a Telecom modulator could be a wild card for the near future. In the recent 10-Q they bothered to change the timeframe for the SLM project with BNS to run "into Q1 2013" but they never bothered to change the timeframe for the Telecom modulator. Hopefully they still expect to complete one in the "near future".
With our luck here if the prophecy held true then 5 minutes before the world ends on friday we'd finally get a PR that announces working devices that are cheap and perform orders of magnitude better than current tech and several multiple billion dollar commercial contracts...
Still think there's a chance that we get an update this week, even if it is nothing but fluff.
From that PR a year ago:
"This creates a substantial business opportunity for us as we begin fabricating devices that can offer better performance, operating at lower voltage and at reduced cost. "
"Dr. Louis Glasgow , the company's Chief Technology Officers remarked, 'Our recently developed material, Perkinamine Indigoâ„¢ has demonstrated a very large electro-optical effect with r33 numbers higher than 250 picometers per volt. It also possesses outstanding thermal stability necessary to fabricate competitive optical devices that will enable a move to organic nonlinear polymer technology.' "
A whole year later and we continue to wait for our FIRST demonstration of a working device...Wonder if we'll at least get a fluff PR like that one next week to hold us over until Q1 2013...
Haha ok I was a bit confused, we are on the same page then.
Six - "insider buying" - good one, made me chuckle.
Should upcoming trial data be shown to be very positive as many of us hope for then I plan to initiate a position in the company Lpath with some of my (potential) gains from PPHM since their drug platform also targets lipids. They are not as far along with their pipeline as PPHM so if PPHM shows success then it would bode well for the other company as well and could turn into another potential multi-bagger.
VERY eager to see the trial data in the coming months...
GLTA
"Oddone, you can always sell your shares and move on."
propjoe,
Didn't realize that I came off as such a harsh critic compared to others who also voice frustration from time to time?? Like you, I am still hopeful that they have some good things in the works and will hold a majority of my shares until they show their hand. I just wish they'd communicate with us a little better so we have a clue where they're at. It's been a long 4 years, I'm sure you can/do understand.
X,
Alex Jen is credited as an author to that paper (and so is Larry Dalton) and the modulator uses an "AJL8" chromophore. That has to be one of Alex Jen's chromophores.
Not sure why you might believe any dots are connected to Lightwave except that Lightwave would like to build one of those types of modulators.
My hope is that in the next PR Lightwave gives us a definitive roadmap of where they are going with their existing materials, including details on devices and planned timelines. I'm getting really tired of the waiting (without seeing any results) game.
Sorry F2, couldn't resist!
Also want to point out that m.barryville's prediction of ~$6 per share by the end of the year is not looking good (what a shocker).
Would love a PR about a working device. Unfortunately I still think that's a few months away due to the continued "characterization" of Indigo and other Perk variations both in and out of devices. At the very least I'd think we'd get another update similar to the one put out at the end of October. Heck, maybe they'll surprise us with the announcement of a new successor material to Indigo that everyone has now changed their focus to ;)
After reading today's PR does it sound to anyone else like the Phase II results for first line NSCLC and Pancreatic cancer will be out in the 1st quarter of 2013 instead of by end of 2012?
Either way, I imagine this will probably be discussed further in the conference call on Monday..
It's surprising how well the price has held up in the absence of news over the last few months. I agree with whoever suggested that Lightwave might be trying to raise money right now as a requirement of whatever business arrangement they are trying to finalize. If they're hitting LPC hard I'd imagine they'd have raised near a million dollars since the share price reached a dollar + back in mid-October. I know we were all excited by the progress update we received in October but to anyone outside of us long term fans the significance wouldn' hit home so I don't see any other reason for the slightly higher volume and price stability.
I think we're all expecting an update in the next 2 weeks so I guess we'll find out soon if we're going to start our annual share price ascent. It's almost hard to believe it has already been a year since we received the news about Indigo and Leonberger that briefly sent the share price to over $3.
I don't think Marcelli needs to go but that's jmo. I think as COO he is now in the right place and that he and Zelibor in their respective positions should play to the company's advantage considering their knowledge of the company and the key players they are dealing with, as well as the small size of Lightwave. Of course if Zelibor were to step aside as CEO fora merger who knows, he may bump Marcelli out completely or down another notch in the ranks.
With that said, I wouldn't mind seeing Marcelli's salary decreased and Cordovano gone since I really have no clue what Steve does there except issue a PR once a month and respond to some investor questions. From what I understand from his linkedin page (maybe it has since changed or I'm getting him mixed up but) it seems like he is working full time on another business venture so IMO he doesn't deserve a 6 figure salary from Lightwave.
I'd have to agree. After that PR today it sounds to me like they are waiting on completion of the new AR box and a test run in a manufacturing environment before any revenue producing deals will be announced. At least they provided a timeframe though. By end of 1st quarter 2013 it sounds like things will start to heat up again but they really didn't mention anything due near term (this month or next). Will sell all my shares today until we get closer to March 2013. Already lost 30% but might be able to make it up elsewhere in the meantime rather than sit and wait.
"If a deal does close, who becomes the CEO?"
Great question Joe, I was wondering this myself. I guess that probably depends on whether they are planning on a merger or not. I imagine that if they instead decide to form a joint venture or went with some other variation of business combination that they wouldn't have to make that decision.
I'm also thinking that by now in addition to Perk NR they must be close to having regular Perk ironed out too. Looking forward to the next PR..
Good thoughts F2. I'm really looking forward to hearing from them that they have the coating process down too. Once they get that process down I'd think it opens the door for them to be able to coat and test not only the LSS devices but also their own internal Telecom Modulator and/or SLM. After today we'll be into the last month of the year and only have about 2.5-3 weeks to see any last PRs before everything shuts down until 2013. Next year should be pretty exciting if all goes well.
Luxtera would be pretty amazing and best case scenario IMO but someone on this board has mentioned hearing rumblings through the grapevine that the company Lightwave is neogtiating a "business combination" with is local to Delaware.
Next time the share price "mysteriously" starts rising I think it will be followed by news involving the planned business combination. We will see..